Today, the US Food and Drug Administration (FDA) approved prademagene zamikeracel cellular sheets (pz-cel, Zevaskyn), the first autologous cell-based gene therapy for treating wounds in adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback